trial · primary record
Dexamethasone
Carcinoma, Non-Small-Cell Lung
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 68 |
| Primary completion | 2027-09-30 |
| Primary endpoint | Percentage of Participants With Infusion-related Reactions (IRRs) at Cycle 1 Day 1 |
| Registry ID | NCT05663866 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:55:54.081Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05663866
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Dexamethasone · approval
- Dexamethasone · compound